HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potassium

An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
Networked: 18489 relevant articles (632 outcomes, 1768 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pitt, Bertram: 51 articles (01/2022 - 03/2003)
2. Rossignol, Patrick: 34 articles (09/2021 - 11/2011)
3. Kovesdy, Csaba P: 26 articles (01/2022 - 09/2007)
4. Lin, Shih-Hua: 26 articles (01/2022 - 05/2002)
5. Zannad, Faiez: 26 articles (01/2022 - 10/2003)
6. Bakris, George L: 22 articles (01/2022 - 03/2004)
7. Weir, Matthew R: 22 articles (10/2021 - 01/2005)
8. Palmer, Biff F: 20 articles (01/2022 - 09/2007)
9. Hoorn, Ewout J: 19 articles (10/2022 - 06/2006)
10. Appel, Lawrence J: 19 articles (11/2021 - 10/2002)

Related Diseases

1. Hypertension (High Blood Pressure)
2. Hyperkalemia
09/01/2023 - " Among patients who received SZC for hyperkalemia treatment, SZC use was associated with a significant reduction of 0.812 mmol/L in serum potassium. Patients with ethnicities other than Chinese, Malay, or Indian had a nominal reduction in K+ of 0.7 mmol/L and this can be accounted for the small sample size of this sub-group. The three main ethnicities which represented more than 95% of the sample showed a significant reduction in K+ levels (all three p<0.001). This is consistent with other studies with SZC which showed efficacy across various ethnicities. Patients who received SZC for hyperkalemia treatment or prevention had a significant lowering of mortality rate. This mortality reduction may have inherent biases and confounders, due to the retrospective clinical audit study design.  Conclusions: Overall, SZC was safe and effective among the audited patients. The efficacy in the real-world setting was similar to previous trials. The novel use of SZC to manage serum potassium when HD sessions are missed, such as during traveling, warrants further investigation due to potentially significant life-saving implications."
12/22/2022 - "Following the initiation of SZC and improvement in hyperkalemia, instructions on the restriction of potassium intake were loosened according to the institutional protocol. "
01/01/2020 - "For PC + HS animals, survival to 48 h was achieved in 6/7 in the AC group and 0/4 in the SC group with an improved median survival in the AC group (48 vs. 18 h, p = 0.011) DISCUSSION: Aggressive and early hyperkalemia treatment prolongs survival while reducing kidney injury and potassium levels in a combat relevant injury model in swine."
10/01/2014 - "Average potassium level pre resin was 5.8_0.26 in group-A and 5.8±0.6 in group-B, which reduced to 4.8±0.5 in group-A and 4.3±0.53 in group-B suggesting the efficacy of both drugs for treatment of hyperkalemia in CKD patients. "
11/01/2011 - "Safety and efficacy of two potassium cocktail formulations for treatment of neonatal hyperkalemia."
3. Hypokalemia
4. Heart Failure
5. Ischemia

Related Drugs and Biologics

1. Sodium
2. Glucose (Dextrose)
3. Insulin (Novolin)
4. Magnesium
5. Calcium
6. Salts
7. Creatinine
8. Adenosine Triphosphate (ATP)
9. Diuretics
10. Solutions

Related Therapies and Procedures

1. Therapeutics
2. Induced Heart Arrest (Cardioplegia)
3. Intravenous Administration
4. Adrenalectomy
5. Renal Dialysis (Hemodialysis)